WHO ICTRP trial
A phase IIb study to evaluate the safety and efficacy of vafidemstat in an adult…
EUCTR2020-003469-20-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2020-003469-20-DE |
|---|---|
| Public title | A phase IIb study to evaluate the safety and efficacy of vafidemstat in an adult borderline personality disorder population |
| Scientific title | A double blind, randomized, placebo-controlled, adaptive 14-week Phase IIb trial to evaluate the efficacy and safety of vafidemstat in an adult borderline personality disorder (BPD) population (PORTICO) - PORTICO |
| Primary sponsor | Oryzon Genomics S.A. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Serbia;Bulgaria;Germany;Spain |
| Conditions | Borderline Personality Disorder (BPD) MedDRA version: 21.1 Level: PT Classification code 10006034 Term: Borderline personality disorder System Organ Class: 10037175 - Psychiatric disorders ;Therapeutic area: Psychiatry and Psychology [F]… |
| Interventions | Product Name: Vafidemstat Product Code: ORY-2001 Pharmaceutical Form: Capsule, hard INN or Proposed INN: VAFIDEMSTAT CAS Number: 1357247-95-0 Other descriptive name: Vafidemstat Concentration unit: mg milligram(s) Concentration type: equal… |
| Registration date | Nov 3, 2021 |
| Target size | 188 |
| Secondary IDs | CL07-ORY-2001;2020-003469-20-ES |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: